More Early Breast Cancer Patients Could Be Spared Chemo, Trial Suggests

(MedPage Today) -- At the American Society of Clinical Oncology (ASCO) meeting, results from the OPTIMA trial suggested that genomic testing may help identify additional patients with hormone receptor-positive/HER2-negative early breast cancer...